Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway
- Wan-cheng Liu
- Yi-hong Wei
- Jin-Feng Chen
- Xiang-ling Xing
- He-xiao Jia
- Xin-yu Yang
- Ying-jian Huang
- Xiao-min Liu
- Ke Xiao
- Xiao-dong Guo
- Can Can
- A-min Zhang
- Na He
- Hai-lei Zhang
- Dao-xin Ma
2025-06-03